Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 718-725

  Peña, Geber ^a   Cai, Bolin ^a   Ramos, Laura ^a   Vida, Gergely ^a   Deitch, Edwin A ^a   Ulloa, Luis ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CHOLINERGIC SYSTEM; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTOXEMIA; IMMUNE DEFICIENCY; IMMUNOMODULATION; INNATE IMMUNITY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEPSIS; SPLEEN CELL; SPLENECTOMY; SURVIVAL; VAGUS NERVE STIMULATION;

ANIMALS; CECUM; ENDOTOXEMIA; IMMUNITY, INNATE; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, NUDE; NEUROIMMUNOMODULATION; PUNCTURES; RANDOM ALLOCATION; RECEPTORS, NICOTINIC; SEPSIS; T-LYMPHOCYTES, REGULATORY; VAGUS NERVE;

EID: 79960492402     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100013     Document Type: Article

References (70)

1. Sands, K. E., D. W. Bates, P. N. Lanken, P. S. Graman, P. L. Hibberd, K. L. Kahn, J. Parsonnet, R. Panzer, E. J. Orav, D. R. Snydman, et al; Academic Medical Center Consortium Sepsis Project Working Group. 1997. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278: 234-240.
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310.
3. Angus, D. C. 2007. Caring for the critically ill patient: challenges and opportunities. JAMA 298: 456-458. (Pubitemid 47124067)
4. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664. (Pubitemid 18005583)
5. Dinarello, C. A. 2004. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr. Opin. Pharmacol. 4: 378-385.
6. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9: 517-524.
7. Ulloa, L., and K. J. Tracey. 2005. The "cytokine profile": a code for sepsis. Trends Mol. Med. 11: 56-63.
8. Ulloa, L., M. Brunner, L. Ramos, and E. A. Deitch. 2009. Scientific and clinical challenges in sepsis. Curr. Pharm. Des. 15: 1918-1935.
9. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852. (Pubitemid 36019637)
10. Abraham, E., P. F. Laterre, J. Garbino, S. Pingleton, T. Butler, T. Dugernier, B. Margolis, K. Kudsk,W. Zimmerli, P. Anderson, et al; Lenercept Study Group. 2001. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit. Care Med. 29: 503-510.
11. Steinman, L. 2004. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5: 575-581.
12. Sternberg, E. M. 2006. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6: 318-328.
13. Borovikova, L. V., S. Ivanova, M. Zhang, H. Yang, G. I. Botchkina, L. R. Watkins, H. Wang, N. Abumrad, J.W. Eaton, and K. J. Tracey. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
14. Tracey, K. J. 2010. Understanding immunity requires more than immunology. Nat. Immunol. 11: 561-564.
15. Wang, H., M. Yu, M. Ochani, C. A. Amella, M. Tanovic, S. Susarla, J. H. Li, H. Wang, H. Yang, L. Ulloa, et al. 2003. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388. (Pubitemid 36157937)
16. Wang, H., H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E. J. Miller, et al. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10: 1216-1221.
17. Ulloa, L. 2005. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov. 4: 673-684.
18. Tracey, K. J. 2002. The inflammatory reflex. Nature 420: 853-859. (Pubitemid 36019638)
19. Bernik, T. R., S. G. Friedman, M. Ochani, R. DiRaimo, S. Susarla, C. J. Czura, and K. J. Tracey. 2002. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J. Vasc. Surg. 36: 1231-1236.
20. Altavilla, D., S. Guarini, A. Bitto, C. Mioni, D. Giuliani, A. Bigiani, G. Squadrito, L. Minutoli, F. S. Venuti, F. Messineo, et al. 2006. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock. Shock 25: 500-506.
21. Cai, B., F. Chen, Y. Ji, L. Kiss, W. J. de Jonge, C. Conejero-Goldberg, C. Szabo, E. A. Deitch, and L. Ulloa. 2009. Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J. Cell. Mol. Med. 13 (9B): 3774-3785.
22. van Westerloo, D. J., I. A. Giebelen, S. Florquin, M. J. Bruno, G. J. Larosa, L. Ulloa, K. J. Tracey, and T. van der Poll. 2006. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130: 1822-1830.
23. Pullan, R. D., J. Rhodes, S. Ganesh, V. Mani, J. S. Morris, G. T. Williams, R. G. Newcombe, M. A. Russell, C. Feyerabend, G. A. Thomas, et al. 1994. Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330: 811-815.
24. Huston, J. M., M. Ochani, M. Rosas-Ballina, H. Liao, K. Ochani, V. A. Pavlov, M. Gallowitsch-Puerta, M. Ashok, C. J. Czura, B. Foxwell, et al. 2006. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203: 1623-1628.
25. van Westerloo, D. J., I. A. Giebelen, S. Florquin, J. Daalhuisen, M. J. Bruno, A. F. de Vos, K. J. Tracey, and T. van der Poll. 2005. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191: 2138-2148.
26. Henrickson, M., J. Reid, J. S. Bellet, S. S. Sawchuk, and R. Hirsch. 1995. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11). Transplantation 60: 828-835.
27. Cretney, E., A. P. Uldrich, F. W. McNab, D. I. Godfrey, and M. J. Smyth. 2008. No requirement for TRAIL in intrathymic negative selection. Int. Immunol. 20: 267-276.
28. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, et al. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1: 496-501.
29. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, R. E. Schmieg, Jr., J. J. Hui, K. C. Chang, D. F. Osborne, B. D. Freeman, J. P. Cobb, T. G. Buchman, and I. E. Karl. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166: 6952-6963.
30. Qin, S., H. Wang, R. Yuan, H. Li, M. Ochani, K. Ochani, M. Rosas-Ballina, C. J. Czura, J. M. Huston, E. Miller, et al. 2006. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203: 1637-1642.
31. Ramos, L., G. Peña, B. Cai, E. A. Deitch, and L. Ulloa. 2010.Mast cell stabilization improves survival by preventing apoptosis in sepsis. J. Immunol. 185: 709-716.
32. Downing, J. E., and J. A. Miyan. 2000. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol. Today 21: 281-289.
33. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77. (Pubitemid 26130005)
34. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNFalpha. Nature 381: 77-80.
35. Pena, G., B. Cai, E. A. Deitch, and L. Ulloa. 2010. JAK2 inhibition prevents innate immune responses and rescues animals from sepsis. J. Mol. Med. 88: 851-859.
36. Parrish, W. R., M. Rosas-Ballina, M. Gallowitsch-Puerta, M. Ochani, K. Ochani, L. H. Yang, L. Hudson, X. Lin, N. Patel, S. M. Johnson, et al. 2008. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol. Med. 14: 567-574.
37. Rosas-Ballina, M., M. Ochani, W. R. Parrish, K. Ochani, Y. T. Harris, J. M. Huston, S. Chavan, and K. J. Tracey. 2008. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. USA 105: 11008-11013.
38. Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5: 606-616.
39. Felten, D. L., S. Y. Felten, D. L. Bellinger, S. L. Carlson, K. D. Ackerman, K. S. Madden, J. A. Olschowki, and S. Livnat. 1987. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100: 225-260.
40. Felten, S. Y., K. S. Madden, D. L. Bellinger, B. Kruszewska, J. A. Moynihan, and D. L. Felten. 1998. The role of the sympathetic nervous system in the modulation of immune responses. Adv. Pharmacol. 42: 583-587.
41. Straub, R. H., J. Westermann, J. Schölmerich, and W. Falk. 1998. Dialogue between the CNS and the immune system in lymphoid organs. Immunol. Today 19: 409-413. (Pubitemid 28389702)
42. Venet, F., C. S. Chung, G. Monneret, X. Huang, B. Horner, M. Garber, and A. Ayala. 2008. Regulatory T cell populations in sepsis and trauma. J. Leukoc. Biol. 83: 523-535.
43. O'Mahony, C., H. van der Kleij, J. Bienenstock, F. Shanahan, and L. O'Mahony. 2009. Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297: R1118-R1126.
44. Shevach, E. M. 2011. The resurrection of T cell-mediated suppression. J. Immunol. 186: 3805-3807.
45. de Jonge, W. J., and L. Ulloa. 2007. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151: 915-929.
46. Saeed, R. W., S. Varma, T. Peng-Nemeroff, B. Sherry, D. Balakhaneh, J. Huston, K. J. Tracey, Y. Al-Abed, and C. N. Metz. 2005. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201: 1113-1123.
47. Peña, G., B. Cai, J. Liu, E. P. van der Zanden, E. A. Deitch, W. J. de Jonge, and L. Ulloa. 2010. Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis. Eur. J. Immunol. 40: 2580-2589.
48. de Jonge, W. J., E. P. van der Zanden, F. O. The, M. F. Bijlsma, D. J. van Westerloo, R. J. Bennink, H. R. Berthoud, S. Uematsu, S. Akira, R. M. van den Wijngaard, and G. E. Boeckxstaens. 2005. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6: 844-851.
49. Peña, G., B. Cai, E. A. Deitch, and L. Ulloa. 2010. JAK2 inhibition prevents innate immune responses and rescues animals from sepsis. J. Mol. Med. 88: 851-859.
50. Peña, G., B. Cai, J. Liu, E. P. van der Zanden, E. A. Deitch, W. J. de Jonge, and L. Ulloa. 2010. Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis. Eur. J. Immunol. 40: 2580-2589.
51. Reid, M. M. 1994. Splenectomy, sepsis, immunisation, and guidelines. Lancet 344: 970-971. (Pubitemid 24306545)
52. Morgan, M. S., and J. G. Cruickshank. 1993. Prevention of postsplenectomy sepsis. Lancet 341: 700-701.
53. Bernard, G. R., J. L. Vincent, P. F. Laterre, S. P. LaRosa, J. F. Dhainaut, A. Lopez-Rodriguez, J. S. Steingrub, G. E. Garber, J. D. Helterbrand, E. W. Ely, C. J. Fisher Jr.; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344: 699-709.
54. Vincent, J. L., Q. Sun, and M. J. Dubois. 2002. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin. Infect. Dis. 34: 1084-1093.
55. Graf, J., G. S. Doig, D. J. Cook, J. L. Vincent, and W. J. Sibbald. 2002. Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit. Care Med. 30: 461-472.
56. Hotchkiss, R. S., P. E. Swanson, B. D. Freeman, K. W. Tinsley, J. P. Cobb, G. M. Matuschak, T. G. Buchman, and I. E. Karl. 1999. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27: 1230-1251.
57. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
58. Monneret, G., A. L. Debard, F. Venet, J. Bohe, O. Hequet, J. Bienvenu, and A. Lepape. 2003. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31: 2068-2071.
59. Venet, F., A. Pachot, A. L. Debard, J. Bohé, J. Bienvenu, A. Lepape, and G. Monneret. 2004. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD252 lymphocytes. Crit. Care Med. 32: 2329-2331.
60. MacConmara, M. P., A. A. Maung, S. Fujimi, A. M. McKenna, A. Delisle, P. H. Lapchak, S. Rogers, J. A. Lederer, and J. A. Mannick. 2006. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann. Surg. 244: 514-523.
61. Scumpia, P. O., M. J. Delano, K. M. Kelly, K. A. O'Malley, P. A. Efron, P. F. McAuliffe, T. Brusko, R. Ungaro, T. Barker, J. L. Wynn, et al. 2006. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J. Immunol. 177: 7943-7949. (Pubitemid 44846310)
62. Wisnoski, N., C. S. Chung, Y. Chen, X. Huang, and A. Ayala. 2007. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27: 251-257.
63. Offner, H., S. Subramanian, S. M. Parker, C. Wang, M. E. Afentoulis, A. Lewis, A. A. Vandenbark, and P. D. Hurn. 2006. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176: 6523-6531.
64. Guarini, S., M. M. Cainazzo, D. Giuliani, C. Mioni, D. Altavilla, H. Marini, A. Bigiani, V. Ghiaroni, M. Passaniti, S. Leone, et al. 2004. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc. Res. 63: 357-365.
65. Flood, J. F., G. E. Smith, and J. E. Morley. 1987. Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. Science 236: 832-834.
66. Luyer, M. D., J. W. Greve, M. Hadfoune, J. A. Jacobs, C. H. Dejong, and W. A. Buurman. 2005. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J. Exp. Med. 202: 1023-1029.
67. Bernik, T. R., S. G. Friedman,M.Ochani, R. DiRaimo, L. Ulloa, H.Yang, S. Sudan, C. J. Czura, S. M. Ivanova, and K. J. Tracey. 2002. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195: 781-788.
68. Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148: 2724-2730.
69. Calandra, T., B. Echtenacher, D. L. Roy, J. Pugin, C. N. Metz, L. Hültner, D. Heumann, D. Männel, R. Bucala, and M. P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6: 164-170.
70. Yan, J. J., J. S. Jung, J. E. Lee, J. Lee, S. O. Huh, H. S. Kim, K. C. Jung, J. Y. Cho, J. S. Nam, H. W. Suh, et al. 2004. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10: 161-167.